PharmaShots | Incisive News in 3 Shots

Subscribe Now

Identification

Acceleron Signs a License Agreement with Fulcrum for the Identification of Therapies to Treat Pulmonary Diseases

Acceleron Signs a License Agreement with Fulcrum for the Identification of Therapies to Treat Pulmonary Diseases

December 31, 2019

Roche Reports Launch of First CDx VENTANA PD-L1 (SP142) Assay Identifying TNBC Patients Eligible for Treatment with Tecentriq (atezolizumab)

Roche Reports Launch of First CDx VENTANA PD-L1 (SP142) Assay Identifying TNBC Patients Eligible for Treatment with Tecentriq (ate...

August 29, 2019

Roche Launches Ventana HER2 Dual ISH CDx for the Identification of Breast and Gastric Cancer

Roche Launches Ventana HER2 Dual ISH CDx for the Identification of Breast and Gastric Cancer

April 23, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us